comprehensive -WSS

comprehensive

author：knowledge 2025-09-06 02:06:45 - browse：6312

Senate Finance Committee Chair Ron Wyden (D-Ore.) Leah Millis/Pool via AP

WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to clamp down on drug middlemen, but kicked the can down the road on some of the more challenging policies.

The bill would offer some more transparency into the business practices of pharmacy benefit managers, ensure PBMs aren’t skimming off of the money they send to insurers, prohibit them from overcharging insurers, and ensure certain fees in the Medicare program aren’t tied to a drug’s price.

“It’s pretty hard to get 26 votes around here,” Finance Chair Ron Wyden (D-Ore.) said after the vote. “So we’re thrilled.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Juul spent big to court Black leaders to promote its e

knowledge

WSS

Medicare drug price negotiation’s day in court

Bill would stop addiction treatment from triggering child abuse inquiry

VC firm General Catalyst wants to buy a health system

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

ARCH Venture Partners is raising $3 billion for a life sciences fund

Chemotherapy drug shortage eases slightly but still widespread

leisure time

comprehensive

focus

Cancer drug shortages should be causing more outrage

VC firm General Catalyst wants to buy a health system

Psychedelics group wrestles with new pharma identity

When women are denied an abortion, their children fare worse than peers

Heart attack and stroke risk calculators need revising

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

At least 13 dead in Texas as scorching temps continue

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

23andMe had bad news about my health. I wish a person had delivered it

SAMSHA loosens regulations on methadone treatment centers

explore

What to expect at HLTH 2023, the health care industry conference

Vertigo drug brings hope for rare neuron disorder, Niemann

Was Amgen transparent enough on FDA's concern on cancer drug?

New Ultima Genomics DNA sequencer can read genome for $100

A $475,000 price tag for a new cancer drug: crazy or meh?

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

knowledge

explore

knowledge

Wikipedia